Possible role for TNF-alpha in early embryopathy associated with maternal diabetes in the rat.
Tumor necrosis factor (TNF) bioactivity was assessed in culture media conditioned with uterine cells collected from control or diabetic rats on days 5 and 8 of pregnancy. On both days, diabetic uterine cells released significantly more biologically active TNF than did control cells, and this activity was significantly decreased by the addition of anti-TNF-alpha antibodies but not by the addition of normal IgG when WEHI 164 cells were used as a target. When uterine tissues from day 5 or day 8 pregnant diabetic rats were tested by Northern blot analysis, TNF-alpha mRNAs were twofold more abundant than in control samples, but the difference was not statistically significant (P = 0.086 and 0.100, respectively). Immunohistochemical analysis of diabetic day 5 uterine sections revealed that most of the TNF-alpha synthesis occurs in the epithelium lining the uterine lumen. Finally, the growth of day-5 embryos in culture medium conditioned with day-5 diabetic uterine cells was significantly reduced when compared with that of embryos in medium conditioned with control cells. Embryonic development was markedly improved when anti-TNF-alpha antibodies were added to the diabetic-cell conditioned medium. Our data support the hypothesis that TNF-alpha may be implicated in the developmental deficiencies observed in preimplantation embryos from pregnant diabetic rats.
Pampfer
S
S
Physiology of Human Reproduction Research Unit, University of Louvain Medical School, Brussels, Belgium.
Vanderheyden
I
I
Wuu
Y D
YD
Baufays
L
L
Maillet
O
O
De Hertogh
R
R
D000818:Animals; D000013:Congenital Abnormalities / Q000209:etiology*; D017077:Culture Media, Conditioned; D046508:Culture Techniques; D003921:Diabetes Mellitus, Experimental / Q000150:complications* / Q000503:physiopathology; D047108:Embryonic Development; D005260:Female; D007150:Immunohistochemistry; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000503:physiopathology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D015854:Up-Regulation; D014599:Uterus / Q000378:metabolism
D017077:Culture Media, Conditioned; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha